{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:56:52Z","timestamp":1794956212483,"version":"4.9.1"},"reference-count":38,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,10,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic lymphoproliferative disorders of natural killer cells (CLPD-NKs) and T-cell large granular lymphocytic leukemias (T-LGLs) are clonal lymphoproliferations arising from either natural killer cells or cytotoxic T lymphocytes (CTLs). We have investigated for distribution and functional significance of mutations in 50 CLPD-NKs and 120 T-LGL patients by direct sequencing, allele-specific PCR, and microarray analysis. STAT3 gene mutations are present in both T and NK diseases: approximately one-third of patients with each type of disorder convey these mutations. Mutations were found in exons 21 and 20, encoding the Src homology 2 domain. Patients with mutations are characterized by symptomatic disease (75%), history of multiple treatments, and a specific pattern of STAT3 activation and gene deregulation, including increased expression of genes activated by STAT3. Many of these features are also found in patients with wild-type STAT3, indicating that other mechanisms of STAT3 activation can be operative in these chronic lymphoproliferative disorders. Treatment with STAT3 inhibitors, both in wild-type and mutant cases, resulted in accelerated apoptosis. STAT3 mutations are frequent in large granular lymphocytes suggesting a similar molecular dysregulation in malignant chronic expansions of NK and CTL origin. STAT3 mutations may distinguish truly malignant lymphoproliferations involving T and NK cells from reactive expansions.<\/jats:p>","DOI":"10.1182\/blood-2012-06-435297","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T04:51:20Z","timestamp":1343969480000},"page":"3048-3057","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":385,"title":["STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia"],"prefix":"10.1182","volume":"120","author":[{"given":"Andres","family":"Jerez","sequence":"first","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Clemente","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Koskela","sequence":"additional","affiliation":[{"name":"Hematology Research Unit, Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"Penn State Hershey Cancer Institute, Penn State Hershey College of Medicine, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok","family":"Peng Ng","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Olson","sequence":"additional","affiliation":[{"name":"Penn State Hershey Cancer Institute, Penn State Hershey College of Medicine, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej","family":"Przychodzen","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Afable","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Gomez-Segui","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Guinta","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Durkin","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"McGraw","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Penn State Hershey Cancer Institute, Penn State Hershey College of Medicine, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimmo","family":"Porkka","sequence":"additional","affiliation":[{"name":"Hematology Research Unit, Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"List","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"Mustjoki","sequence":"additional","affiliation":[{"name":"Hematology Research Unit, Department of Medicine, Division of Hematology, Helsinki University Central Hospital, Helsinki, Finland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[{"name":"Penn State Hershey Cancer Institute, Penn State Hershey College of Medicine, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111809105664900_B1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia.","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"issue":"1","key":"2019111809105664900_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes.","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"key":"2019111809105664900_B3","article-title":"International Agency for Research on Cancer, World Health Organization.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th Ed"},{"key":"2019111809105664900_B4","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th Ed"},{"issue":"9","key":"2019111809105664900_B5","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","article-title":"Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.","volume":"95","author":"Bareau","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"2019111809105664900_B6","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1182\/blood-2008-02-136382","article-title":"Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.","volume":"112","author":"Epling-Burnette","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111809105664900_B7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1084\/jem.179.2.609","article-title":"Clonal populations of T cells in normal elderly humans: the T cell equivalent to \u201cbenign monoclonal gammapathy.\u201d","volume":"179","author":"Posnett","year":"1994","journal-title":"J Exp Med"},{"issue":"8","key":"2019111809105664900_B8","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/blood-2002-08-2408","article-title":"Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C\/E and NKD2D killer cell receptors.","volume":"101","author":"Bigouret","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111809105664900_B9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/mp.50.2.77","article-title":"Routine diagnosis of large granular lymphocytic leukaemia by Southern blot and polymerase chain reaction analysis of clonal T cell receptor gene rearrangement.","volume":"50","author":"Ryan","year":"1997","journal-title":"Mol Pathol"},{"issue":"5","key":"2019111809105664900_B10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2002-12-3898","article-title":"Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.","volume":"102","author":"Zambello","year":"2003","journal-title":"Blood"},{"issue":"20","key":"2019111809105664900_B11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia.","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111809105664900_B12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"issue":"10","key":"2019111809105664900_B13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2009.009191","article-title":"Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.","volume":"94","author":"Mohan","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"2019111809105664900_B14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2019111809105664900_B15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V98.1.165","article-title":"Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations.","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"issue":"3","key":"2019111809105664900_B16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1309\/3A32DTVMH640M2QA","article-title":"Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques.","volume":"121","author":"Morice","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2019111809105664900_B17","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.4049\/jimmunol.172.3.1960","article-title":"Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses.","volume":"172","author":"O'Keefe","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"2019111809105664900_B18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2005-05-1884","article-title":"Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles.","volume":"107","author":"Zeng","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111809105664900_B19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.","volume":"82","author":"Wen","year":"1995","journal-title":"Cell"},{"key":"2019111809105664900_B20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3.","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"2019111809105664900_B21","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1073\/pnas.0409894102","article-title":"A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.","volume":"102","author":"Song","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111809105664900_B22","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V81.9.2381.2381","article-title":"Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.","volume":"81","author":"Zambello","year":"1993","journal-title":"Blood"},{"issue":"9","key":"2019111809105664900_B23","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2003-02-0400","article-title":"Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes.","volume":"103","author":"Epling-Burnette","year":"2004","journal-title":"Blood"},{"issue":"16","key":"2019111809105664900_B24","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2011-02-338517","article-title":"Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.","volume":"118","author":"Clemente","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111809105664900_B25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","article-title":"Autocrine IL-6 signaling: a key event in tumorigenesis?","volume":"13","author":"Grivennikov","year":"2008","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111809105664900_B26","first-page":"2948","article-title":"Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine\/paracrine stimulation of the interleukin 6\/gp130 cytokine system.","volume":"63","author":"Sriuranpong","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"2019111809105664900_B27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0501-29","article-title":"SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.","volume":"28","author":"Yoshikawa","year":"2001","journal-title":"Nat Genet"},{"issue":"3","key":"2019111809105664900_B28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest"},{"issue":"16","key":"2019111809105664900_B29","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome.","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"issue":"7157","key":"2019111809105664900_B30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"6","key":"2019111809105664900_B31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10875-010-9452-z","article-title":"Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation.","volume":"30","author":"Kumanovics","year":"2010","journal-title":"J Clin Immunol"},{"issue":"6","key":"2019111809105664900_B32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3816\/CLM.2007.n.022","article-title":"Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome.","volume":"7","author":"Wallet","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"9","key":"2019111809105664900_B33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0002-9343(00)00386-7","article-title":"Leukemia of large granular lymphocytes and rheumatoid arthritis.","volume":"108","author":"Starkebaum","year":"2000","journal-title":"Am J Med"},{"issue":"2","key":"2019111809105664900_B34","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.165.2.1138","article-title":"Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis.","volume":"165","author":"Namekawa","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"2019111809105664900_B35","first-page":"660","article-title":"Systemic and local expression of perforin in lymphocyte subsets in acute and chronic rheumatoid arthritis.","volume":"30","author":"Gulan","year":"2003","journal-title":"J Rheumatol"},{"issue":"4","key":"2019111809105664900_B36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10495-009-0317-y","article-title":"Cell death in rheumatoid arthritis.","volume":"14","author":"Korb","year":"2009","journal-title":"Apoptosis"},{"issue":"4","key":"2019111809105664900_B37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2567.2007.02679.x","article-title":"Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3.","volume":"122","author":"Kim","year":"2007","journal-title":"Immunology"},{"issue":"2","key":"2019111809105664900_B38","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood-2007-07-101345","article-title":"Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.","volume":"111","author":"Ward","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/15\/3048\/1358687\/zh804112003048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/15\/3048\/1358687\/zh804112003048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T07:13:54Z","timestamp":1594538034000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/15\/3048\/30607\/STAT3-mutations-unify-the-pathogenesis-of-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,11]]},"references-count":38,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2012,10,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-435297","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,11]]}}}